MedPath

Evaluation of the efficacy of oxybutynin and imipramine in the management of detrusor instability

Not Applicable
Completed
Conditions
Incontinence
Urological and Genital Diseases
Registration Number
ISRCTN58226681
Lead Sponsor
Medical Research Council (MRC) (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
345
Inclusion Criteria

1. Failed conservative therapies for urinary dysfunction (nursing interventions)
2. Urodynamicaly proven detrusor instability

Exclusion Criteria

1. Pregnancy
2. Malignancy
3. Fistula
4. Contra-indications to the use of oxybutynin or imipramine
5. Bladder outflow obstruction (measured urodynamically)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical assessment using urinary diaries and 24 hour home pad tests.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath